Outlook Therapeutics Incs. (OTLK) PT Raised to $8 at Brookline Capital Markets, Following Clinical Business Update

August 3, 2021 11:28 AM

Brookline Capital Markets analyst Kumaraguru Raja raised the price target on Outlook Therapeutics Incs. (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found